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ARTICLE
Mitigation of off-target toxicity in CRISPR-Cas9
screens for essential non-coding elements
Josh Tycko 1,12, Michael Wainberg2,12, Georgi K. Marinov1,12, Oana Ursu1, Gaelen T. Hess1, Braeden K. Ego1,
Aradhana1, Amy Li1, Alisa Truong1, Alexandro E. Trevino3,4, Kaitlyn Spees1, David Yao1, Irene M. Kaplow 2,5,
Peyton G. Greenside1,6, David W. Morgens1, Douglas H. Phanstiel1,7,8, Michael P. Snyder 1, Lacramioara Bintu4,
William J. Greenleaf 1,9,10, Anshul Kundaje1,2 & Michael C. Bassik 1,11
Pooled CRISPR-Cas9 screens are a powerful method for functionally characterizing regulatory
elements in the non-coding genome, but off-target effects in these experiments have not
been systematically evaluated. Here, we investigate Cas9, dCas9, and CRISPRi/a off-target
activity in screens for essential regulatory elements. The sgRNAs with the largest effects in
genome-scale screens for essential CTCF loop anchors in K562 cells were not single guide
RNAs (sgRNAs) that disrupted gene expression near the on-target CTCF anchor. Rather,
these sgRNAs had high off-target activity that, while only weakly correlated with absolute off-
target site number, could be predicted by the recently developed GuideScan specificity score.
Screens conducted in parallel with CRISPRi/a, which do not induce double-stranded DNA
breaks, revealed that a distinct set of off-targets also cause strong confounding fitness effects
with these epigenome-editing tools. Promisingly, filtering of CRISPRi libraries using Guide-
Scan specificity scores removed these confounded sgRNAs and enabled identification of
essential regulatory elements.
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CRISPR-Cas9 screens
1–4 are a powerful tool for functionally
characterizing genes and non-coding cis-regulatory ele-
ments (CREs). In particular, growth screens have been
employed to discover genes essential for fitness under various
conditions1,2,5,6. CRISPR screens can also be used to interrogate
the non-coding genome7–13. In some instances, active Cas9
nuclease is used to edit candidate functional elements (e.g.,
transcription factor (TF) motifs) at the sequence level by gen-
erating indels8,13. Alternatively, the epigenetic environment of a
locus can be perturbed using nuclease-dead dCas9 fused to
effector domains that can recruit chromatin silencers that modify
histones with repressive marks (CRISPRi)7,14–18 or activators that
recruit transcriptional machinery (CRISPRa)9,17,19.
A challenge in interpreting CRISPR screens is that Cas9 can
bind to off-target genomic sites, in a manner that depends on the
specificity of the sgRNA sequence20–22. For active Cas9, off-target
activity at perfectly matched sites23–26 or sites with 1–2
mismatches27,28 has been shown to reduce cell fitness and con-
found gene-targeting growth screens. This reduction in cell fitness
could be due to DNA damage from off-target cleavage events.
Conversely, for CRISPRi/a, the impact of off-target activity on
gene-targeting growth screens is thought to be minimal3. How-
ever, the impact of off-target activity on screens for essential non-
coding regulatory elements has not been systematically studied
for any perturbation.
There are reasons to expect off-target effects may be more of an
issue in non-coding screens than in gene screens. For gene
screens, large targetable windows are present within which all
sgRNAs that induce frameshifting indels would be expected to
have similar effects (i.e., a complete knockout), making the
selection of highly specific sgRNAs relatively straightforward. On
the other hand, screens of non-coding elements with active Cas9
often require the use of lower specificity sgRNAs because CRE
components, such as TF motifs, present narrower targeting
windows with fewer available sgRNAs.
Despite these challenges, CRISPR-Cas9 screens enable the
systematic perturbation and characterization of candidate CREs
(cCREs). A major class of cCREs that has not been functionally
dissected genome-wide is CTCF sites in chromatin loop anchors.
CTCF binding is enriched at the boundaries that partition
interphase vertebrate genomes into TADs (Topologically Asso-
ciated Domains)29,30; pairs of convergently oriented CTCF motifs
appear to specify chromatin loop anchors30,31. Chromatin loops
and TADs are thought to constrain enhancer-promoter interac-
tions, adding specificity to the cis-regulatory wiring that connects
genes with distal CREs. Deletions and inversions of CTCF sites
result in reorganization of TADs31 and occasionally in gene
expression changes32–36. Moreover, disruptions of CTCF occu-
pancy have been suggested to be involved in tumorigenesis due to
pathogenic rewiring of enhancer-promoter interactions35,37–39.
Global degradation of CTCF protein showed that CTCF is
required for TAD formation and maintenance and resulted in 370
differentially expressed genes after one day40, albeit with only
small fold-changes. However, such global perturbations do not
reveal the functional importance of individual CTCF sites.
To address this question, we performed a genome-wide non-
coding screen for essential CTCF sites in chromatin loop anchors
in the K562 leukemia cell line. We discovered that the dominant
source of signal in our screen was not due to deregulated gene
expression but was instead consistent with CRISPR-Cas9 off-
target activity causing reductions in cell fitness, despite filtering
the sgRNAs to have no perfect or 1-mismatch off-target sites. We
found that the recently developed GuideScan-aggregated Cutting
Frequency Determination (CFD) specificity score accurately
predicted sgRNAs with confounding off-target activity and out-
performed a previous score, as well as the simple number of off-
target sites as a metric for identifying and removing these
sgRNAs. This discovery led us to systematically explore the
impact of off-target activity across different perturbations in non-
coding screens. Interestingly, we observed that CRISPRi/a are
similarly vulnerable to confounding off-target activity that sig-
nificantly reduces cell fitness despite using non-nucleolytic dCas9.
We then retrieved specificity scores for all sgRNAs in the human
genome and investigated which cCREs can be reliably screened
with high-specificity sgRNAs. Cas9 screens for essential func-
tional motifs are severely limited by low availability of high-
specificity sgRNAs, whereas CRISPRi/a libraries can be properly
filtered to avoid confounders as their sgRNAs can be selected
from a larger targeting window. Together, our results provide
principles for the design and interpretation of high-throughput
measurements of regulatory element essentiality.
Results
Genome-scale CRISPR screens for essential CTCF loop
anchors. To identify essential CTCF sites, we performed a Cas9
growth screen with an sgRNA library targeting 4,022 CTCF
motifs known to be at loop anchor sites in the K562 cell line
according to available Hi-C and CTCF ChIP-seq evidence30,41
(Fig. 1a, Supplementary Data 1). The library included 2 to
5 sgRNAs per CTCF site that had an expected cleavage site within
the motif. The growth effects, measured as guide enrichment
from the original sgRNA library plasmid pool to the end of the
screen, were highly reproducible between the two independently
transduced biological replicates (r2= 0.75, Fig. 1b). We observed
strong growth effects from the internal positive control sgRNAs
that target the exons of essential genes, as well as from sgRNAs
targeting the BCR-ABL copy number amplification, which are
expected to cause substantial toxicity due to the creation of
multiple DNA double-stranded breaks23–26. We validated 15
individual sgRNAs using a competitive growth assay, which
confirmed the growth effects observed in the pooled screen (r2=
0.69, Fig. 1c).
To better understand the mechanistic basis for these fitness
effects, we characterized the transcriptional and chromatin
landscape of K562 cell lines carrying mutations induced by
individual sgRNAs with validated growth effects. We chose hits
where 2–3 sgRNAs targeting the same CTCF site had strong
fitness effects and where changes in distal gene regulation could
affect a gene that was essential in our previous Cas9 and CRISPRi/
a gene screens in K562. First, we sought to confirm that sgRNAs
targeting CTCF sites can disrupt CTCF binding by performing
CTCF ChIP-seq on Cas9-expressing cells transduced with
individual sgRNAs. Indeed, Cas9-induced indels specifically
eliminated CTCF binding at the targeted CTCF, while CTCF
occupancy at untargeted sites in the immediate vicinity or
elsewhere in the genome remained unchanged (Supplementary
Fig. 1A, B). However, a case-by-case examination of each site
revealed a more complex picture. For two sites, where either only a
single CTCF motif was present or the central CTCF motif relative
to the ChIP-seq peak was the target of the sgRNA, we observed
complete elimination of CTCF binding as expected (Supplemen-
tary Fig. 1c, right-hand side panels). In two other cases, multiple
clustered CTCF motifs were present within the ChIP-seq peak;
CRISPR-Cas9 perturbation specifically resulted in elimination of
ChIP-seq signal over the targeted motif, as could be expected
(middle panels). The last two cases (left-hand side panels) featured
a site within a peak that is not strongly occupied in these K562
cells and a guide targeting a site nearby but outside the observed
ChIP-seq peak, likely due to misannotation of the loop anchor
motif. These last two examples naturally raised questions
regarding the source of their reproducible fitness effects.
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When we carried out gene expression measurements (both by
qPCR and RNA-seq; Supplementary Fig. 1D–M) on cell lines
carrying CTCF motif indels, we did not observe significant
changes in transcript levels for genes located in the genomic
neighborhood of the targeted CTCF sites. Similarly, ATAC-seq
experiments did not reveal significant changes in chromatin
accessibility (Supplementary Fig. 1N). Altogether, these experi-
ments did not nominate changes in gene expression or chromatin
structure near the CTCF motifs as likely causes of the observed
growth effects for any of the motifs we aimed to validate. Instead,
we wondered whether off-target activity could explain these
results, since off-target effects have previously been found
to generate confounding signal in CRISPR-Cas9 growth
screens23–25,27,28 and the sgRNA fitness effects in our screen
were weakly correlated with their number of predicted off-target
sites in the human genome (Pearson’s r= 0.13, Fig. 1d).
Specificity model reveals confounder in CTCF screens. To
further explore the possibility that off-target activity was
responsible for the screen results, despite library filtering, we
retrieved specificity scores42 for every sgRNA. These sgRNA-level
aggregate scores are determined by (1) searching reference gen-
omes for off-target binding locations, (2) predicting the Cas9
activity across those sites given the pattern of mismatches
between the sgRNA and the genomic DNA, and (3) aggregating
these predicted Cas9 activities into a final score. Different
implementations of this workflow have resulted in a variety of
software tools providing specificity scores20,42–46. We found that
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Fig. 1 GuideScan specificity filtering of a genome-scale CRISPR-Cas9 screen for essential CTCF loop anchors. a Schematic of CTCF loop anchor motif
screen, with 2 to 5 sgRNAs targeting each CTCF motif. b Fitness effects are reproducible between independently transduced biological replicates of the
screen. sgRNAs targeting essential gene exons or the BCR-ABL amplification drop out during the growth screen, as expected. Guide enrichment values are
the log2(fold-change) of an sgRNA’s sequencing counts from after the screen compared with the original plasmid pool, computed with the casTLE screen
analysis software5. c The growth effects of CTCF motif-targeting sgRNA are validated in individual competitive growth assays after lentiviral delivery of
single guides to K562-Cas9 cells. Error bars are standard deviation of three technical replicates. d Comparison of sgRNA fitness effects with the number of
off-target sites with 2-3 mismatches. Any sgRNAs with off-target sites with only 0 or 1 mismatch, as determined by the GuideScan search algorithm, are
excluded. e Low-specificity score guides are significantly enriched among CTCF motif-targeting guides with fitness effects. The Fisher’s exact test provided
the p-value for the association between fitness effect and specificity using the 2 × 2 contingency table of the numbers of guides in each quadrant based on
the thresholds drawn in black lines. Numbers in corners correspond to the number of CTCF site-targeting guides (blue circles) in the quadrant. The off-
target search was done with GuideScan, which retrieves all off-target locations with 2 or 3 mismatches to the sgRNA spacer. sgRNAs with >1 perfect
matches to the genome or >0 off-target locations with only 1 mismatch are not searchable within the GuideScan trie data structure and were excluded from
this analysis. f Filtering for high-specificity scores removes all CTCF motifs with concordant evidence of fitness effects from multiple sgRNAs. Gray circles
are screen biological replicates. Source data are available in the Source Data file
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aggregated CFD specificity scores from GuideScan42 correlate
very well with data from Guide-seq21, an unbiased off-target
measurement assay for Cas9 (Spearman’s ρ=−0.84, Supple-
mentary Fig. 2A). These GuideScan scores outperformed MIT
aggregate specificity scores20 (Supplementary Fig. 2B). Notably,
the selected sgRNAs that conferred reproducible fitness effects
without affecting nearby essential gene expression had moderate
MIT specificity scores ranging from 20–54 (mean= 34) but very
low GuideScan scores ranging from 0–0.24 (mean= 0.06).
GuideScan scores are a weighted function of all off-target loca-
tions with 2 or 3 mismatches to the sgRNA spacer that considers
the position, number, and nucleotide identity of the mismatches.
Importantly, this analysis focuses on further refinement of rea-
sonably designed sgRNAs, as all very low-specificity sgRNAs with
>1 perfect match in the genome or any off-target locations with
only 1 mismatch had already been excluded.
In the full screen data, we observed a striking bias for low
specificity scores among the sgRNAs that confer large fitness
effects (p= 1.1e−31, Fisher’s exact test, Fig. 1e). Indeed, the
majority (76%) of CTCF motif-targeting sgRNAs that have guide-
level log2(fold-change) ≤−2 also had GuideScan specificity scores
≤0.2 (on a scale of 0 to 1, where 0 indicates least specificity or
greatest off-target activity), representing an 8.4-fold odds ratio. In
the case of our CTCF screen, 4% of CTCF loop anchors had
strong evidence of essentiality (Guide enrichment log2(fold-
change) ≤−2) with a single sgRNA, but only 0.2% had such
evidence from multiple sgRNAs (Fig. 1f). This disparity is
unexpected given that the sgRNAs targeting the same site should
have similar effects but is consistent with the sgRNAs having
different off-target effects. After filtering for high-specificity
sgRNAs with the GuideScan score, the number of CTCF loop
anchors with evidence of essentiality from multiple sgRNAs
dropped to zero (out of 2968 motifs targeted with multiple high-
specificity sgRNAs). Together, these results experimentally
validated the new GuideScan specificity score as an effective
predictor of off-target activity and a more useful parameter for
screen filtering than the absolute number of off-target sites or a
previous aggregate specificity score.
Dense-tiling CTCF loop anchors with pooled Cas9 screens. To
further test whether off-target activity could explain the hits from
the CTCF motif screen, we designed a dense-tiling sgRNA library
targeting 270 CTCF sites, including full tiling of each such site (all
possible sgRNAs within 1 kb), using up to 400 sgRNAs per site
(Fig. 2a). We chose CTCF sites from four categories: hits called by
casTLE analysis before filtering with GuideScan scores, the Hi-C
loop partners of these hits, non-hits, and the loop partners of the
non-hits (see Methods section). We expected three possible
results from densely tiling the loop anchors: (1) truly essential
CTCF motifs would result in a strong peak of signal from high-
specificity sgRNAs that generate indels near the motif (i.e.,
+/−20 bp), (2) regions that were essential for reasons distinct
from the CTCF motif, such as being copy number
amplified23,25,26,47, would result in uniformly strong growth
effects from both low-specificity and high-specificity sgRNAs
irrespective of whether the sgRNAs overlap the motifs, and (3)
non-functional motifs would only have strong signal from low-
specificity sgRNAs, if any. This dense-tiling screen was performed
at high coverage (~12,000 cells per sgRNA) and yielded highly
reproducible guide effect measurements (r2= 0.92, Supplemen-
tary Fig. 3A). As expected, positive control sgRNAs targeting ten
essential genes were strongly depleted (Supplementary Fig. 3B).
We observed uniform depletion of high-specificity and low-
specificity sgRNAs tiling regions near the BCR-ABL amplification
but not elsewhere (Supplementary Fig. 3C, D), as expected. Both
high-specificity and low-specificity sgRNAs had strong growth
effects when targeting exons of essential genes but no effect in the
neighboring introns (Fig. 2b), demonstrating that the dense-tiling
screen can discern the short functionally relevant sequences of
coding exons from background with high fidelity. Strikingly, the
great majority (93%) of sgRNAs tiled within the 1 kb CTCF loop
anchor regions that had a strong fitness effect were, again, low-
specificity guides with GuideScan scores ≤0.2 (p= 2.3e−233,
Fisher’s exact test, Supplementary Fig. 3E). While the previous
motif-targeting library only used 2–5 sgRNAs per motif, this
dense-tiling library included all possible guides overlapping a
window of +/−20 bp of the CTCF motif centers. Despite this
increase in sgRNA density, after filtering with GuideScan scores,
we still found zero CTCF motifs with evidence of essentiality
from multiple high-specificity sgRNAs (Fig. 2c and Supplemen-
tary Fig. 3F, G). We therefore concluded that the observed hits in
the CTCF screens were consistent with off-target activity. This
result suggests (but does not conclusively prove) that the CTCF
loop anchors we tested in K562 are not essential for cell growth in
normal conditions, which appears consistent with recent obser-
vations that degron-mediated depletion of loop anchor proteins
can have minimal effects on transcription40,48–51. Notably,
functional redundancy of CTCF sites or inefficient genome
editing could also lead to false negatives. While we could not fully
explain why no CTCF sites were convincing hits in these screens,
we consistently found strong evidence that GuideScan scores
reveal confounding off-target activity and set out to explore the
utility of this approach on other non-coding CRISPR screens.
Off-target activity in Cas9 screens of enhancers. To test our
ability to dissect the essentiality of non-coding elements beyond
chromatin loop anchors, we also densely tiled two enhancers
which regulate expression of the essential gene GATA1 in K562
cells, with 110 and 174 sgRNAs to span the entire 611 bp and 1.1
kb regions, respectively. These enhancers, named eGATA1 and
eHDAC6, were previously identified in a CRISPRi tiling growth
screen in K5627, but their constituent functional motifs remain
uncharacterized. We sought to identify these with higher reso-
lution dissection by Cas9 dense-tiling. These screens revealed
narrow peaks defined by 1–2 sgRNAs that overlapped known TF
ChIP-Seq motifs within the DNase hypersensitive sites in the
enhancers41 (Fig. 2d). However, these sgRNAs were again of low
specificity, raising doubts that their targets were in fact essential
motifs and motivating a careful validation of the sgRNAs and
their effects on GATA1 expression. We installed the sgRNAs
individually into K562 cells and found that this resulted in indel
mutations (37–98%) in the genomic DNA at the corresponding
target motifs (Supplementary Fig. 4A). These sgRNAs also caused
significant growth phenotypes (Supplementary Fig. 4B) which
correlated with the growth effects measured in the pooled screen
(r2= 0.76, Supplementary Fig. 4C). However, there were no
concordant changes in GATA1 expression as measured by qPCR,
Western blot, or flow cytometry (Fig. 2e–g and Supplementary
Fig. 4D). These experiments demonstrate that even sgRNAs tar-
geting TF motifs in bona fide enhancers can have reproducible
growth screen effects that are unrelated to the expression of their
nearby essential gene, and that the GuideScan specificity score is
useful to help identify such confounded sgRNAs. Further, these
results suggest that even dense-tiling can potentially miss critical
motifs or, more interestingly, that no single sgRNA might be
sufficient to disrupt the activities of these enhancers.
CRISPRi/a off-target activity causes large fitness effects.
CRISPRi and CRISPRa have also been used to screen for func-
tional non-coding elements, but the potentially confounding
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effect of off-target activity with these platforms in the context of
non-coding essential regulatory elements has not been studied.
To systematically compare these technologies, we performed a
tiling screen around three essential genes in K562 cells (GATA1,
MYB, and ZMYND8); the library consisted of a total of
32,791 sgRNAs targeting a total of 794 kb including candidate
regulatory elements, annotated exons and intervening genomic
space. We screened this library with four different CRISPR-Cas9
platforms: active Cas9, nuclease-dead dCas9, CRISPRi (dCas9-
KRAB17), and CRISPRa (dCas9-SunTag-VP6452) (Fig. 3a). As
expected, in the active Cas9 screen we observed strong negative
fitness effects for sgRNAs targeting exons, and in the CRISPRi
ba
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Fig. 2 Low-specificity sgRNAs confound identification of essential motifs in dense-tiling screen of loop anchors and enhancers. a A dense-tiling Cas9
growth screen was performed with sgRNAs densely tiling two types of regions: (1) 1 kb windows around select hit and non-hit CTCF loop anchors from the
CTCF motif screen and (2) two enhancers of GATA1, previously called eGATA1 and eHDAC6. b As a positive control, we verified that the dense-tiling
screen correctly maps the boundaries of exons of essential genes with high-specificity sgRNAs. Each point is the average enrichment of two biological
replicates and the bar is the standard error. c Dense-tiling screen results from a 1 kb region centered on a motif that was a false positive hit in the original
motif-targeting screen (targeted with sgRNAs 15776 and 15777 and also shown in Fig. 1 and Supplementary Fig. 1). All evidence for the essentiality of a
CTCF motif comes from low-specificity sgRNAs. Motifs in ChIP-seq peaks are shown as black boxes and CTCF motifs as green boxes. d Dense-tiling screen
results from two regions containing enhancers of the essential gene GATA1. sgRNAs selected for validation studies are labeled (e.g., 1 L represents the first
sgRNA with a low specificity score). ChromHMM is colored according to the 15-state scheme76 (briefly, reds are predicted promoter states, yellows are
enhancer states, and greens are other transcriptionally active states). e The enhancer motif-targeting sgRNAs identified in d do not significantly decrease
GATA1 expression according to qPCR (p > 0.05, ANOVA). Each dot is a sgRNA infection biological replicate. f The sgRNAs identified in d do not
significantly decrease GATA1 protein expression according to Western blot. g The sgRNAs identified in d do not significantly decrease GATA1 protein
expression according to flow cytometry for GATA1 protein level. Additional validation data are shown in Supplementary Fig. 4. Source data are available in
the Source Data file
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screen we observe strong signals for sgRNAs targeting known
essential enhancers and promoters7,53 (Fig. 3b and Supplemen-
tary Fig. 5A–D). We also found that for CRISPRa and
dCas9 screens, sgRNAs that targeted transcriptional start sites
(TSS) of essential genes exhibit negative fitness effects (Fig. 3b
and Supplementary Fig. 5D); for dCas9, this observation may be
due to the binding of dCas9 interfering with the transcriptional
initiation machinery17,54.
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However, for each screening modality we also noticed
sgRNAs with strong negative fitness effects that did not target
candidate regulatory elements or annotated coding sequences
and for which neighboring sgRNAs did not exhibit concordant
effects (Fig. 3b). Again, we suspected that the growth effects of
these guides might be due to off-target activity and used
GuideScan aggregate specificity scores in order to investigate
this possibility. Indeed, we observed a striking enrichment for
low-specificity sgRNAs among the set of sgRNAs with strong
negative fitness effects in the Cas9, CRISPRi, and CRISPRa
screens (p < 1.9e−21 for all, Fisher’s exact test, Fig. 3c). We
questioned whether the sets of sgRNAs with putative off-target
activity were highly overlapping between each CRISPR-Cas9
platform. Strikingly, this was not what we observed. In fact, sets
of low-specificity sgRNAs that show significant fitness effects
with Cas9, CRISPRi, or CRISPRa are largely non-overlapping
(Fig. 3d), suggesting the off-target effects are specific to each
CRISPR-Cas9 platform. Thus, off-target growth effects appear
to be a function of both the sites targeted by an sgRNA and the
mode of perturbation.
We questioned whether these off-target growth effects were
purely a function of the absolute number of off-target sites or
specific to a subset of off-target sites. We and others have
shown that, in the context of coding gene screens, the number
of perfect matches or 1-mismatch off-targets correlates with
growth phenotypes27,28. However, the analyses presented here
do not include any sgRNAs with perfect genomic matches at
any other place in the genome, nor sgRNAs with 1-mismatch
off-targets. Across all four CRISPR-Cas9 platforms used in the
tiling screens, the GuideScan score was predictive of off-target
effects on cell fitness (Fig. 3c and Supplementary Fig. 6A), yet
there was very weak correlation between growth effects and
the absolute number of off-target sites (with 2 or 3 mismatches
each), especially for CRISPRi/a (Supplementary Fig. 6B, C).
Indeed, some outlier sgRNAs with thousands of off-target sites
had no effects on growth. Thus, when designing and
interpreting screens, the propensity to bind or cut as captured
by the specificity score should be considered, rather than
simply the number of off-target binding locations. These
propensities are predicted for each off-target location by the
CFD score44 as a weighted function of the mismatch number,
position, and nucleotide identity, and then aggregated across
all off-target locations into a GuideScan aggregate specificity
score. Lastly, the optimal GuideScan score cutoff for filtering
out false positives while retaining library density varies slightly
but is approximately 0.2 for CRISPRi/a and Cas9 (Supplemen-
tary Fig. 6D).
High-specificity CRISPRi libraries identify essential CREs.
While the appearance of confounding off-target activity in
CRISPRi screens was unexpected, GuideScan scores proved useful
to identify confounded sgRNAs. We next asked if the removal of
low-specificity sgRNAs would improve the reliable identification
of expected regulatory elements (e.g., the TSS and the two
enhancers of GATA1). We thus filtered out guides with Guide-
Scan scores ≤ 0.2, which did indeed remove confounded sgRNAs
while preserving strong CRISPRi signal at these enhancers and
promoters (highlighted regions in Fig. 3e).
To confirm that these high-specificity sgRNAs in peaks had
bona fide effects on the expression of GATA1, we delivered single
guides by lentivirus and measured GATA1 expression by qPCR
and Western blot (Fig. 3f, g). Whereas targeting the GATA1 TSS
or a CRISPRi peak 500 bp downstream of the TSS both resulted in
near-complete knockdown (to 4–9% of protein levels in the
control cells), the enhancer-targeting sgRNAs provided partial
knockdown (to 40–63% of control protein levels), and expression
levels were highly correlated between RNA-level qPCR and
protein-level Western blot (R2= 0.92, Supplementary Fig. 7A).
Flow cytometry for GATA1 protein levels confirmed that
CRISPRi enhancer repression resulted in partial knockdown
across the population of cells, as opposed to complete silencing
observed when targeting the TSS (Fig. 3h). Together, these
experiments validated that the high-specificity sgRNAs from the
tiling CRISPRi screen resulted in on-target repression of the
expected essential gene.
We next wondered if off-target activity might confound other
CRISPRi/a non-coding growth screens for other types of
elements. To directly compare the different CRISPR-Cas9
platforms with a shared library of sgRNAs, we performed parallel
screens with our CTCF motif-targeting sgRNA library in K562
using CRISPRi, CRISPRa, dCas9, and Cas9 (Supplementary Fig.
8A–C). When we analyzed the specificity scores of this library, we
found that these CRISPRi and CRISPRa screens again showed a
significant bias towards low-specificity sgRNAs having strong
growth effects (Supplementary Fig. 8D). The Cas9 screen in this
experiment was maintained with lower coverage (cells per
sgRNA) and was thus noisier than the Cas9 screen in Fig. 1;
interestingly, we found that this enrichment for low-specificity
sgRNAs was less pronounced but remained highly significant (p
= 1.1e−9, Fisher’s exact test), showing that the signature of off-
target effects can be disguised in noisy screens. As with our tiling
library, we found that the sets of low-specificity sgRNAs that
show significant fitness effects with Cas9, CRISPRi, or CRISPRa
are largely non-overlapping, reproducing the previous observa-
tion that off-target effects are specific to each CRISPR-Cas9
Fig. 3 GuideScan specificity filtering of CRISPRi library reduces false positives. a Four parallel screens were conducted tiling the loci of essential growth
genes GATA1, MYB, and ZMYND8 using the four platforms Cas9, CRISPRa, CRISPRi and dCas9. b Zoomed-in view of screen data around essential gene
GATA1. Highlighted are regulatory elements with known effects on cell growth: enhancers eGATA1 and eHDAC6, and the GATA1 transcription start site.
ChromHMM is colored according to the 15-state scheme76 (briefly, reds are predicted promoter states, yellows are enhancer states, and greens are other
transcriptionally active states). Each point is the average enrichment of two screen biological replicates and the bar is the standard error. c Enrichment of
growth effects among low-scoring sgRNAs with no perfectly matching and no 1-mismatch off-target sites. p-value from the Fisher’s exact test for the 2 × 2
table with quadrants as drawn and guide counts as labeled in the corners; these counts include all the sgRNAs regardless of the categories indicated in
colors. d Clustering of low-specificity sgRNAs reveals that each perturbation has off-target activity that reduces cell fitness with a unique subset of the low-
specificity sgRNAs. Shown are the subset of sgRNAs that are upstream of eGATA1 or downstream of eHDAC6 (i.e., sgRNAs with predominantly off-target
effects) and that also have a strong guide enrichment≤−3 in at least one replicate. Color scale is the log2 fold-change guide enrichment. e Filtering of
sgRNAs in panel B with GuideScan specificity scores reduces noise. f After filtering, the CRISPRi sgRNAs in peaks have validated effects on GATA1
expression by qPCR (p < 0.05, ANOVA). Each dot is a sgRNA infection biological replicate. g Effects of indicated sgRNAs on GATA1 protein expression
measured by Western blot. h Effects of indicated sgRNAs on GATA1 protein expression measured by flow cytometry. Here, cells expressing an sgRNA and
mCherry were co-cultured with the blank parental cell line, stained for GATA1 protein, and analyzed by flow cytometry. We then compared the distribution
of GATA1 protein level between the mCherry + and blank control cells from the same sample. Horizontal lines show the median and quartiles. Source data
are available in the Source Data file
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perturbation (Supplementary Fig. 8E). Again, the CRISPRi/a
growth phenotypes were not reproduced when employing dCas9
with the same sgRNAs, demonstrating these off-target effects are
not due to dCas9 binding alone.
To investigate the generality of these CRISPRi off-target
growth effects across cell types, we retrieved GuideScan specificity
scores for guide libraries from published screens targeting the
promoters of genes with dCas9-KRAB-MeCP2 in SH-SY5Y and
HAP1 cells18. These screens found reproducible, validated hits,
but also found that some sgRNAs targeting known non-essential
genes had unexpected growth effects. Here, we found that these
sgRNAs also had lower specificity scores (Supplementary Fig.
9A). These results suggest that using CRISPRi with low-specificity
sgRNAs can be associated with strong fitness effects in other cell
types. Similarly, we found evidence that low-specificity sgRNAs
targeting Cas9 near the TSS of genes were also enriched for fitness
effects in several other cell types in previously published screens
(Supplementary Fig. 9B). Together, these results suggest that our
findings can be generally useful for filtering and interpreting
growth screens, regardless of the cell type used.
Impact of low-specificity sgRNAs on non-coding screen design.
Finally, we investigated the extent to which non-coding elements
can be targeted with high-specificity sgRNA libraries. To address
this question, we characterized the distribution of GuideScan
specificity scores for a number of possible screen designs. We
observed that our tiling screen and CTCF site screen libraries
contained significantly more low-specificity sgRNAs than Bru-
nello44, a genome-wide coding gene-targeting library (p < 0.0001,
Mann–Whitney test, Fig. 4a), reflecting the inherently poorer
specificity of sgRNA libraries that densely tile regions or target
relatively small motifs. We then designed libraries targeting all
candidate cis-regulatory elements (or ccREs) which were identi-
fied in the ENCODE SCREEN databases55,56. At the time of our
analysis, the SCREEN databases contained 1.31 million individual
ccREs, with a median length over 200 bp (Supplementary Fig.
10A). We specifically focused on CRISPRi/a epigenetic pertur-
bation designs and imposed a minimum requirement of including
at least 5 sgRNAs of sufficiently high specificity for each element
(to enable robust statistical analyses of functional effects at the
element level). We find that 89% of SCREEN cCREs can be tar-
geted with ≥5 sgRNAs at a GuideScan cutoff of 0.2 (Supple-
mentary Fig. 10B) although this varies by type of target element.
For example, we find that 62% of human lncRNA TSS elements
can be targeted with ≥5 CRISPRi sgRNAs with a specificity score
>0.2, even when selecting sgRNAs from a conservative window of
only +/−100 bp from the TSS (Fig. 4b). Overall, most ccREs can
be targeted with epigenome editing tools even after filtering the
sgRNAs that are most likely to be confounded by off-target
effects.
However, most ccREs are composed of multiple regulatory
units, such as transcription factor binding sites (TFBSs), and
achieving mechanistic understanding of cCRE function will
require perturbing these regulatory units, individually or in
combination. To assess the ability of Cas9 to enable more fine-
grained regulatory element mapping, we designed motif-level
screens for 27 different human TFs targeting all of their
annotated and occupied motifs in K562 cells and summarized
the specificity score distributions for each. We find that guide
specificity filtering restricts the ability to target TF motifs to a
varying extent for different TFs: for example, only 31% of CEBPB
motifs can be targeted with even a single overlapping sgRNA at a
GuideScan cutoff of 0.2 (Fig. 4c), whereas for TFs such as ETS1,
64% motifs can be targeted with 5 or more such guides. Taken as
a whole, Cas9 TF motif screens, as well as splice site screens
(Supplementary Fig. 10C), are subject to more limiting design
restrictions than screens targeting cCREs with CRISPRi/a,
because the sgRNAs for these Cas9 non-coding screens must
overlap the narrow target element directly while sgRNAs for
CRISPRi/a cCRE screens can be selected from a larger targeting
window. These designs provide a guideline for focusing future
screens for essential regulatory elements on the motifs and cCREs
that can be targeted with high-specificity guides, and we provide
scripts here to both aid in the analysis of previous libraries for
specificity, as well as the design of new sgRNA libraries for non-
coding elements with greater specificity.
Discussion
Here, we found that off-target activity confounds Cas9, CRISPRi,
and CRISPRa screens for essential regulatory elements in K562
cells by conducting several screens using sgRNA libraries
designed to edit motifs and tile regions of interest in an unbiased
fashion. Notably, these sgRNAs had already been filtered to lack
0–1 mismatch off-target sites; i.e., this confounding activity was
found in sgRNAs with only 2+ mismatch off-target sites, which
may have passed previous design requirements. Importantly, use
of GuideScan aggregate specificity scores to identify sgRNAs with
only 2+ mismatch off-targets and their propensity to mediate
Cas9 binding/cutting could resolve most of these issues. We
present a strategy and software to use this score to filter screens
for essential non-coding elements.
Surprisingly, we find that low-specificity sgRNAs are the
dominant confounding factor not only for active Cas9 screens but
also for dCas9-mediated perturbations such as CRISPRi and
CRISPRa. Cas9 generates double-strand breaks (DSB), so a large
number of off-targets for a given sgRNA could result in a major
fitness effect due to cellular toxicity as a result of activation of the
DNA damage response and apoptosis23,25–27,53, regardless of the
location of off-target sites. In contrast, dCas9-recruited epigenetic
perturbations do not generate DSBs, and their off-target effects
are expected to be location-dependent. Interestingly, these off-
target effects cannot be fully accounted for by dCas9 binding
itself, as we tested the same sgRNAs with all four CRISPR-Cas9
platforms, and nearly all sgRNAs showed unmeasurable growth
effects with dCas9 alone. Future studies of the mechanisms of
CRISPRi/a off-target toxicity will improve our understanding of
the cellular response to these perturbations and enable improved
experimental designs. This is especially relevant for non-coding
screens, which may be particularly vulnerable to confounding off-
target activity given the need to target small regions with few
available sgRNAs. As an example of the impact that off-target
effects can have, growth screens targeting CTCF sites in K562
cells returned only hits that on closer examination were con-
founded by off-target activity. None of the CTCF sites that we
characterized in more detail in cell lines expressing sgRNAs had a
measurable impact on gene expression or chromatin states in the
genomic neighborhood (Supplementary Fig. 1). Dense-tiling of
those motifs also did not find concordant evidence of CTCF site
essentiality from multiple high-specificity sgRNAs, which further
supports the conclusion that the hits were false positives.
Although this is unexpected, it is potentially consistent with
recent studies that reported acute global degradation of either all
CTCF protein40 or all of the loop anchor cohesin component
RAD21 in cells49 did not result in dramatic changes in gene
expression. Individual CTCF site deletions at the boundaries of
TADs containing developmental genes were recently reported to
have no effect on nearby gene expression or developmental
phenotypes in mouse embryos48,50. Therefore, our results appear
consistent with other evidence that individual CTCF sites are
dispensable for gene regulation in many contexts.
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However, our CTCF screen data could also include false
negatives; it remains possible that some of the loop anchor CTCF
motifs we targeted may be functional but redundant, or that
CTCF sites with the greatest functional relevance under standard
growth conditions may not actually be at loop anchors or may be
at locations we did not target efficiently with multiple sgRNAs.
While the targeted loop anchors were called from K562 Hi-C
data, it remains possible that the structural variation of the K562
genome57 leads to lowered CTCF site targeting accuracy or lower
efficiency of disrupting all copies of a CTCF site and thus more
false negatives than would appear in a CTCF site screen in a
different cell type. In terminally differentiated cells, such as K562,
chromatin states may not be dramatically disrupted by the
absence of an individual loop anchor CTCF site. While we cannot
conclusively explain the absence of essential CTCF sites in our
data, the off-target driven false positive CTCF sites exemplified
how off-target activity poses a particular challenge to CRISPR
screens for essential non-coding elements.
Our findings have implications for the design and analysis of
future screens. Given that (1) validation experiments of individual
screen hits are time-intensive and low-throughput, and (2) there
is a growing interest in global analyses of aggregated non-coding
screen data, computational models for filtering out low-specificity
sgRNAs are crucial to identify bona fide hits and to diagnose
systemic problems before data aggregation. We find that off-
target effects on cell fitness are not predictable solely from the
absolute number of off-target sites for these sgRNAs, although
that simple metric is often used when designing and ranking
sgRNAs. In contrast, we find that the data-driven GuideScan
specificity score, which accounts for the position and type of
mismatches to provide a weighted assessment of Cas9’s affinity
for each potential off-target site, provides a more accurate
determination of off-target potential. While the GuideScan off-
target search algorithm has previously been described42, the
GuideScan aggregate specificity score (i.e., aggregating CFD spe-
cificity scores across GuideScan’s list of off-target sites) was not
reported in the literature. We found a striking correlation of this
score with fitness effects in non-coding screens, and also with
direct measurements of off-target cutting using Guide-seq, which
exceed previous scores and suggest the use of this score to filter
non-coding CRISPR screens will be broadly useful.
We find that targeting a substantial fraction of individual
TFBSs with high-specificity sgRNAs when using Cas9 is often
impossible, although this fraction varies widely between different
TFs. This constraint imposes a significant limitation on Cas9
growth screens directed at elements as small as TFBSs (<30 bp).
On the other hand, at the level of an individual cCRE (>150 bp),
sufficiently many high-specificity sgRNAs can generally be found
for CRISPRi and CRISPRa screens. Notably, coding gene screens
also benefit from larger available sequence from which to choose
sgRNAs.
However, GuideScan models only the potential extent of off-
target cleavage activity and very frequently gives low specificity
scores for sgRNAs that have no effect on the phenotypic outcome
of cell growth. One exciting future direction suggested by our
study is the development of models to predict the phenotypic
consequence of off-target activity, which can now be enabled by
high-throughput datasets such as these. By integrating features
including the chromatin state of off-target binding locations and
the essentiality of genes near those off-target locations, it may be
possible to tailor models to predict which particular sgRNAs
would be confounded if used with each CRISPR-Cas9 platform.
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We expect that the impact of low-specificity guides is depen-
dent on the phenotype being screened. Low-specificity sgRNAs
have a greater potential to confound growth screens, likely
because proliferation is affected by many factors in the cell, while
screens employing different selection strategies may be less sen-
sitive to these effects. Studies of cCRE effects that involve mea-
suring the RNA or protein products of cognate genes, separating
cell populations according to expression levels, and then identi-
fying the particular sgRNAs associated with each expression level
may also be less affected by off-target effects. Similarly, experi-
ments that couple CRISPR-Cas9 screens to single-cell readouts of
gene expression58–60 or chromatin accessibility61 may likewise
overcome limitations associated with growth as a readout.
Regardless, limitations remain that will be best addressed by
the development of perturbation systems that either expand the
targetable sequence space or minimize off-targets. Efforts in both
of these directions are ongoing, e.g., devising guide design stra-
tegies that reduce off-target effects such as truncated guides27,62,
engineering high-specificity variants of Cas963,64, and exploring
the possibilities for adapting other CRISPR enzymes without
strict PAM requirements65–68. We expect that the combination of
technological improvements, judicious screen design, and careful
data analysis that explicitly considers guide specificity will enable
the comprehensive functional characterization of the essential
regulatory elements in the human genome.
Materials and methods
Cell lines and cell culture. All experiments presented here were carried out in
K562 cells (ATCC CCL-243)5. Cells were cultured in a controlled humidified
incubator at 37 °C and 5% CO2 in RPMI 1640 (Gibco) media supplemented with
10% FBS (Hyclone), penicillin (10,000 I.U./mL), streptomycin (10,000 µg/mL), and
L-glutamine (2 mM). Experiments were performed in four modified K562 cell lines:
K562 stably expressing SFFV-Cas9-BFP, K562 expressing SFFV-dCas9-BFP, K562
expressing dCas9-SunTag-VP643 (CRISPRa), and K562 expressing SFFV-dCas9-
KRAB-BFP (CRISPRi). The CRISPRa cell line expressing the SunTag system was a
gift from the lab of Jonathan Weissman.
CTCF motif-targeting sgRNA library design. We selected CTCF motifs in loop
anchors to target as follows. We started with 6057 loops present in K562 cells and
focused on the 4,892 loop anchors that had previously annotated motifs over-
lapping ChIP-seq peaks30 for CTCF (using STORM69), such that the CTCF motifs
were convergently oriented into the loop, which is suggested to be the correct
orientation for loop formation. We further restricted to 4172 loop anchor CTCF
motifs that could be targeted with with at least two sgRNAs per site, as defined by
our guide filtering criteria below. Some of these CTCF motif targets were in exons
of genes or near the BCR-ABL amplification, which could result in growth effects
unrelated to CTCF binding, so they were treated separately during analysis,
resulting in a final count of 4022 Type 0 CTCF loop anchor motifs. Finally, a set of
control sgRNAs targeting safe regions was added. Briefly, safe-targeting negative
control sgRNAs are highly filtered to target a non-functional genomic site and
avoid having severe growth effects while controlling for the effect of inducing a
double strand break27. An additional 310 CTCF and Rad21 sites (Types 1–5) were
selected with alternative methods (Supplementary Materials and Methods) and also
targeted with sgRNAs in the library, but these were filtered out during analysis and
not included in Fig. 1 for the sake of clarity and because this small alternative set
was similarly confounded by off-target activity and lacking hits. For sites that
passed our filtering criteria, we selected a maximum of 5 sgRNAs per site. 95% of
these sgRNAs overlapped a K562 CTCF ChIP-seq peak in our CTCF ChIP-
seq data.
To minimize off-target effects, we filtered out sgRNAs that had exact or 1-
mismatch off-target instances within another CTCF site or inside exons of
GENCODEv1970 genes, to avoid confounding activity from targeting multiple
CTCF sites or knocking out genes. We also filtered out guides with >2 0-mismatch,
>10 1-mismatch, >50 2-mismatch, or >200 3-mismatch genome-wide off-targets.
We defined off-target matches by aligning the guides to the hg19 version of the
human genome using BWA ‘aln’ with the flags -N -n 4 -o 0 -k 0 -l 771. However,
the screen data presented in Fig. 1 and Supplementary Fig. 8 is further filtered more
stringently to only display sgRNAs with no perfectly matching and no 1-mismatch
off-target sites as defined by the GuideScan search algorithm. We also filtered out
guides with too low (<20%) or too high (>80%) GC content and guides containing
confounding oligonucleotides that might affect the expression of the guide or PCR
steps, where confounding oligonucleotides are defined as those that either end in
GGGGG, contain TTTT, or contain restriction cut sites (CTGCAG, GAAGAC,
GTCTTC, CCANNNNNNTGG, GCTNAGC).
CTCF sgRNA screen execution. Oligonucleotide libraries (Supplementary Data 1)
were synthesized by Agilent and then cloned into an sgRNA expression vector
pMCB320 (Supplementary Table 1) that had been cut with BstXI and BlpI
restriction enzymes, by ligation with T4 ligase (NEB M0202M). To generate suf-
ficient lentivirus to infect the library into K562 cells, we plated 293 T cells on 15-cm
tissue culture plates. Two hundred and ninety three T cells were transfected with
third-generation packaging plasmids and sgRNA-encoding vectors. After 48 h and
72 h of incubation, lentivirus was harvested. We filtered the pooled lentivirus
through a 0.45-μm PVDF filter (Millipore) to remove any cellular debris. K562 cells
were infected with our lentiviral sgRNA library. Infected cells grew for 3 days
before the cells were selected with puromycin (0.7 μg/mL, Sigma). After 3 days of
selection, infection efficiency was monitored using flow cytometry (BD Accuri C6).
Once the cells reached 90–100% mCherry + cells, they were spun out of selection
and allowed to recover in normal RPMI 1640 media. Cells were then maintained at
3000× coverage (cells per sgRNA). Cells were maintained in log growth conditions
each day by diluting cell concentrations back to a 0.5 × 106 cells/mL. These con-
ditions were used for the Cas9, dCas9, CRISPRi, and CRISPRa screens performed
with this library. After 14 days of growth, cells were spun down (300 × g for 5 min).
Genomic DNA was extracted with Qiagen’s Blood Maxi Kit, and the sgRNA library
composition was sequenced and compared to the plasmid library using casTLE5
version 1.0 (available at https://bitbucket.org/dmorgens/castle).
The screen was repeated in K562-Cas9 cells at 11,000× maintenance coverage
for 23 days, starting from a frozen aliquot of cells after library transfection and
puromycin selection (frozen at day 6). After the screen, genomic DNA was
harvested and sgRNAs were amplified and sequenced. The high-coverage screen
showed better reproducibility between biological replicates (Supplementary Fig.
8C) and was used for all analyses shown in the main text (Fig. 1).
Dense-tiling screen library design. The dense-tiling screen employed densely
tiled sgRNAs in short 1 kb windows around CTCF motifs, enhancers, and exons of
essential genes. First, we densely tiled the regions around the CTCF motif screen
hits as identified by casTLE (see below), a GC-matched set of regions around non-
hit CTCFs, and the loop partner CTCFs that looped to any of these positive or
negative CTCFs in a K562 Hi-C dataset30. Non-hit CTCFs were selected from the
set of CTCF sites with enrichment magnitudes less than 0.5 for all guides in all
motif-targeting Cas9, CRISPRi/a, and dCas9 screens. We selected all sgRNAs
provided by the GuideScan design tool within the CTCF motif and up to 500 bp on
each side, for a total of 1020 bp. For each CTCF hit, we selected a 1020-bp region
around a ‘GC-matched’ non-hit CTCF with a GC content within 5% of the GC
content of the 1020-bp region around the CTCF hit. In addition, we densely tiled
the essential enhancers eGATA1 and eHDAC6 as positive controls and added 1000
safe-targeting guides as negative controls. As an additional positive control, we
included all guides from a 10-guide gene-targeting library27 for the essential genes
CTCF, RAD21, SMC1A, SMC3, MYC, GATA1, MYB, RPS28, RPS29, and RPS3A.
Dense-tiling screen execution. The screen was executed with the same protocol
as the others at a maintenance coverage of approximately 12,000 K562 cells per
sgRNA. After 20 days, genomic DNA was harvested and sgRNAs were amplified
and sequenced with an Illumina NextSeq to a depth of 2333–3153 reads per sgRNA
using the protocol described above.
Tiling screen library design and execution. We designed an sgRNA library
(referred to from now on as the tiling screen library) that would allow us to
compare different CRISPR-Cas9 platforms in an unbiased fashion. To this end, we
decided to focus on a limited set of genes with an already known strong growth
effect, specifically GATA1 [guides covering the genomic region chrX:48544984-
48752721 (in hg19 coordinates), covering a total region of 207.737 kb, with tiling
density 9308/207.737 kb= ~44 guides per kilobase], MYB (guides covering the
genomic region chr6:135402680-135640267, covering a total region of 237.587 kb,
with tiling density 9200/237.587 kb= ~38 guides per kilobase), and ZMYND8
(guides covering the genomic region chr20:45737857-46085556, covering a total
region of 347.699 kb, with tiling density of 14282/347.699 kb= ~41 guides per
kilobase). These regions were determined by tiling the full annotated gene sequence
and then extending the tiling for an additional 100 kb in either direction.
We filtered guides as follows. We discarded guides that had any exact or one-
mismatch targets in DNase-hypersensitive sites55 or exons. We also filtered out
sgRNAs that had any perfect matches in the genome, or >10 1-mismatch, >50 2-
mismatch or >200 3-mismatch genome-wide off-targets. Matches were defined by
aligning the guides to the genome using BWA ‘aln’ with the flags -N -n 4 -o 0 -k 0
-l 771. The screen data presented in Fig. 3c, d and Supplementary Fig. 6 is further
filtered more stringently to only display sgRNAs with no perfectly matching and no
1-mismatch off-target sites as defined by the GuideScan search algorithm.
To allow direct comparison of effect sizes of regulatory elements in the screen
with those of genes, we also included guides targeting the coding regions of the 3
genes of interest (10 guides per gene). Finally, we added a set of 1000 control guides
targeting safe regions as defined previously27.
The screen was executed with the same protocol as the others. After 14 days,
genomic DNA was harvested and sgRNAs were amplified and sequenced using the
protocol described above.
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Screen data analysis. The casTLE v1.0 framework5 was used to process screen
data, including alignment of reads to an index of guide oligos, subsequent guide
filtering, and estimation of effects on cell growth. For growth screens, enrichment
scores were calculated by comparing samples from the final day (day 14, 21, or 23,
depending on the screen) with the plasmid library.
For the CTCF motif screen, we ran makeIndices.py with parameters ‘-s 31 -e 37’
and makeCounts.py with parameters ‘-l 20’; we also grouped sgRNAs that target
the same motif to measure motif-level effects and called hits using combined
biological replicates with a 10% false discovery rate, using the script analyzeCombo.
py. For the dense-tiling screen, we ran makeIndices.py with parameters ‘-s -34 -e
17’ and makeCounts.py with parameters ‘-l 17 -m 0 -s -’. For the tiling screen, we
ran makeIndices.py with parameters ‘-s 11 -e 17’ and makeCounts.py with
parameters ‘-l 19’.
GuideScan-aggregated CFD specificity scores. We retrieved GuideScan v1.042
aggregate specificity scores from the webtool. GuideScan is an off-target search
algorithm that forgoes short string alignment (e.g., BWA) to find off-target loca-
tions and instead recovers locations from a pre-computed trie data structure. The
webtool also reports aggregate specificity scores: these are Cutting Frequency
Determination (CFD) scores (a weighted function of mismatch number, position,
and nucleotide identities)44 for all off-target locations with 2 to 3 mismatches, that
are then aggregated with the summation formula from the CRISPR MIT tool20
(dividing 1 by the sum of 1 plus all the CFDs), such that sgRNAs with more off-
target activity approach GuideScan scores of 0. The webtool does not provide
scores for sgRNAs with multiple perfect genomic matches or any off-targets that
only differ by 1 mismatch, which are assumed to be too poor specificity for use in
experiments, and we also excluded such sgRNAs from the analyses using
GuideScan.
Competitive growth assays. Competitive growth assays were performed with
stable K562 lines expressing Cas9, CRISPRi, or CRISPRa that were lentivirally
transduced with a vector (pMCB320) expressing the sgRNA and mCherry and
then, after 2 to 3 days, selected with puromycin for 3 to 4 days, until the mCherry
+ fraction of cells was >90%. Then 40,000 of these mCherry + cells were mixed 1:1
with blank cells from the parental line (Day 0) in 1 mL of fresh RPMI media and
grown in triplicate or quadruplicate in 24-well plates. The cells were maintained at
a confluence less than 1e6 cells per mL. The changes in the mCherry + proportion
of cells were measured on an Accuri BD C6 flow cytometer on Day 0, 4, and 7 and
gating on mCherry expression in channel FL3.
Motif mapping. Transcription factor motif recognition sequences were mapped
genome-wide using FIMO72 (version 4.12.0 of the MEME-Suite73 using the CIS-BP
database74 as a reference set of position weight matrices).
External datasets. Data on the fitness effect of protein coding genes in K562
cells was obtained from previously published studies5,53. Uniformly processed
ChIP-seq and DNAse-seq datasets were obtained from the ENCODE portal
(https://encodeproject.org). Data on dCas9-KRAB-MeCP2 screens were retrieved
from the published supplementary materials18. Guide-seq data were retrieved from
a publication43 that collected off-target data from several original sources20,21,75.
ChromHMM annotations. ChromHMM76 tracks for K562 chromatin state41 were
retrieved from https://egg2.wustl.edu/roadmap/data/byFileType/
chromhmmSegmentations/ChmmModels/coreMarks/jointModel/final/
E123_15_coreMarks_mnemonics.bed.gz and visualized with the WashU Epigen-
ome Browser77.
ChIP-seq experiments. ChIP-seq experiments were carried out as described78
with some modifications. Briefly, 2e7 K562 cells were pelleted at 500 × g for 5 min
at 4 °C and then resuspended in 1× PBS buffer; 37% formaldehyde solution (Sigma
F8775) was added at a final concentration of 1%. Crosslinking was carried out at
room temperature for 15 min, and then the reaction was quenched by adding 2.5 M
Glycine solution at a final concentration of 0.25M. Crosslinked cells then were
pelleted 500 × g for 5 min at 4 °C, washed with cold 1× PBS buffer, and stored at
−80 °C.
CTCF ChIP was performed using a polyclonal anti-CTCF antibody (Millipore,
07–729). For each reaction, 100 µL of Protein A Dynabeads (Thermo Fisher
10001D) were washed 3 times with a 5 mg/mL BSA (Sigma A9418) solution. Beads
were then resuspended in 1 mL BSA solution and 4 µL of CTCF antibody were
added. Coupling of antibodies to beads was carried out overnight on a rotator at 4 °
C. Beads were again washed 3 times with BSA solution, resuspended in 100 µL of
BSA solution, mixed with 900 µL sonicated chromatin and incubated overnight on
a rotator at 4 °C. Chromatin was sonicated using a tip sonicator (Misonix) after
cells were lysed with Farnham Lysis Buffer (5 mM HEPES pH 8.0, 85 mM KCl,
0.5% IGEPAL, Roche Protease Inhibitor Cocktail), and nuclei were resuspended in
RIPA buffer (1× PBS, 1% IGEPAL, 0.5% Sodium Deoxycholate, 0.1% SDS, Roche
Protease Inhibitor Cocktail). The sonicated material was centrifuged at 14,000 rpm
at 4 °C for 15 min to remove cellular debris, and a portion of the supernatant was
saved as input. After incubation with chromatin, beads were washed 5 times with
LiCl buffer (10 mM Tris-HCl pH 7.5, 500 mM LiCl, 1% NP-40/IGEPAL, 0.5%
Sodium Deoxycholate) by incubating for 10 min at 4 °C on a rotator and then
rinsed once with 1× TE buffer. Beads were then resuspended in 200 µL IP Elution
Buffer (1% SDS, 0.1 M NaHCO3) and incubated at 65 °C in a Thermomixer
(Eppendorf) with interval mixing to dissociate antibodies from chromatin. Beads
were separated from chromatin by centrifugation, Proteinase K was added to the
supernatant and crosslinks were reversed at 65 °C for ~16 h. Input samples (100
µL) were mixed with an equal volume of IP Elution Buffer, Proteinase K was added
and cross-links were reversed together with the ChIP samples. DNA was purified
by phenol-chloroform-isoamyl extraction followed by MinElute column (Qiagen)
clean up. DNA concentration was measured using QuBIT, and libraries were
generated using the NEBNext Ultra II DNA Library Prep Kit for Illumina (NEB,
E7645S). Libraries were sequenced on a NextSeq (Illumina) in a 2 × 75 bp format.
ChIP-seq data processing. Demultipexed fastq files were initially mapped to the
hg19 assembly of the human genome (female version) as 1 × 36mers using Bowtie
v1.0.179 with the following settings: ‘-v 2 -k 2 -m 1 --best --strata’, for quality
assessment purposes (see AQUAS: https://github.com/kundajelab/
chipseq_pipeline) (Supplementary Table 2). For subsequent analyses of CTCF
occupancy, reads were mapped against the female version of the hg19 assembly of
the human genome using the ‘bwa mem’ algorithm in the BWA aligner with
default settings and filtering non-unique and low-quality alignments using sam-
tools71 with the ‘-F 180 -q 30’ options. A consensus set of peaks was derived from
the three safe sgRNA CTCF ChIP-seq datasets as described in the AQUAS pipeline.
FRiP values80 were calculated for each dataset using this set of peak calls. Our peak
set overlapped by 82–89% with different available ENCODE K562 CTCF ChIP-seq
peak sets, while the ENCODE samples overlapped with one another by 73–94%.
Read coverage tracks were generated using custom-written Python scripts. For the
purpose of comparison between datasets and normalizing for differences in ChIP
strength between individual experiments, tracks were rescaled as follows:
Cchr;i
 Dð Þ ¼ Cchr;i Dð Þ 
maxD FRIPð Þ
FRIPD
ð1Þ
Where Cchr;iðDÞ is the normalized coverage (in RPM, or Read Per Million mapped
reads units) of position i on a given chromosome chr in dataset D, and Cchr;i
ðDÞ is
the rescaled coverage.
RNA-seq experiment. 2e7 K562 cells per replicate were pelleted at 500×g for 5
min at 4 °C and then resuspended in 1× PBS buffer. Two replicates were performed
for each sgRNA. RNA extraction was performed as follows: 500 µL of TRIzol was
added to each sample, mixed by inverting the tube, and then 5 min later 100 µL of
chloroform was added. Samples were spun at 12,000 × g for 15 min at 4 °C. The
aqueous layer was transferred to an RNase-free tube and mixed with 300 µL of 70%
ethanol and vortexed. Contents were then transferred to Direct-zol Miniprep
columns (Zymo) and the protocol was followed according to the manufacturer’s
instructions, including the on-column DNaseI treatment. RNA was eluted in 15 µL
of RNase-free water and stored at −80 °C and a separate 2 µL aliquot was set aside
for testing RNA concentration and quality via Nanodrop. RNA-seq libraries were
prepared from 700 ng of total RNA with the TruSeq RNA Library Prep kit v2
(Illumina) low sample protocol, which uses oligo-dT beads to enrich for A-tailed
mRNAs. Library concentration and length was determined with a 2200 Tapestation
System (Agilent) and Qubit (Thermo Fisher Scientific). Libraries were pooled and
sequenced on a Nextseq (Illumina).
RNA-seq data processing and analysis. Paired-end 2 × 50 bp RNA-seq reads
were mapped using version 2.5.3a of the STAR aligner81 against the hg19 version of
the human genome with haplotypes removed but retaining random chromosomes,
with version 19 of the GENCODE annotation70 as a reference. Gene expression
quantification was then carried out on the STAR alignments transformed into
transcriptome space using version 1.3.0 of RSEM82. Differential expression analysis
was performed using DESeq283 with the RSEM estimated read counts per gene as
an input. Mapping and QC statistics are provided in Supplementary Table 3.
ATAC-seq experiments. ATAC-seq experiments were carried out following the
Omni-ATAC-seq protocol84, using two replicates per sgRNA. Briefly, cells were
pretreated with 200 U/ml DNase (Worthington) for 30 min at 37 °C, then washed,
resuspended in cold PBS, and counted. 50,000 cells were resuspended in 1 ml of
cold ATAC-seq resuspension buffer (RSB; 10 mM Tris-HCl pH 7.4, 10 mM NaCl,
and 3 mM MgCl2 in water). Cells were centrifuged at 500×g. for 5 min in a pre-
chilled (4 °C) fixed-angle centrifuge. Cell pellets were then resuspended in 50 μl of
ATAC-seq RSB containing 0.1% NP40, 0.1% Tween-20, and 0.01% digitonin and
incubated on ice for 3 min. After lysis, 1 ml of ATAC-seq RSB containing 0.1%
Tween-20 was added, and the tubes were inverted to mix. Nuclei were then cen-
trifuged for 10 min at 500 × g. At 4 °C. Supernatant was removed and nuclei were
resuspended in 50 μl of transposition mix (25 μl 2× TD buffer, 2.5 μl transposase
(100 nM final), 16.5 μl PBS, 0.5 μl 1% digitonin, 0.5 μl 10% Tween-20, and 5 μl
water). Transposition reactions were incubated at 37 °C for 30 min in a thermo-
mixer with shaking at 1000 r.p.m. Reactions were cleaned up with Zymo DNA
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Clean and Concentrator 5 columns. The ATAC-seq library was then subjected to
PCR amplification with NEBNext (NEB, M0541) for 10-25x cycles (with the
minimal sufficient cycle number determined by qPCR as described85), purified with
a MinElute column (QIAGEN, 28004), and sequenced on an Illumina NextSeq.
ATAC-seq analysis. Paired-end 2 × 36 bp reads were first mapped to the mito-
chondrial genome to assess the fraction of mitochondrial reads in each sample. All
other reads were then mapped to the hg19 genome assembly using BWA as
described above. Statistics are summarized in Supplementary Table 4.
ICE analysis of indels. Cells were harvested and total genomic DNA was isolated
using QuickExtract DNA Extraction Solution (VWR, Radnor, PA, cat# QE09050).
PCR was prepared using 5X GoTaq Green Reaction Buffer and GoTaq DNA
Polymerase (Promega, Madison, WI, cat# M3005), 10 mM dNTPs, and primers
designed approximately 250–350 basepairs upstream and 450–600 basepairs
downstream of the predicted cut site. PCR reactions were run on a C1000 Touch
Thermo Cycler (Bio-Rad). PCR products were then purified over an Econospin
DNA column (Epoch, Missouri City, TX, cat# 1910-250) using Buffers PB and PE
(Qiagen, Hilden, Germany, cat# 19066 and cat# 19065). Sanger sequencing ab1
data were obtained from Quintara Biosciences and editing efficiency of knockout
cell lines were analyzed using Synthego’s online ICE Analysis Tool (https://ice.
synthego.com)86.
RT-qPCR experiments. RNA from 100,000 K562 cells was extracted with RNA
QuickExtract (Lucigen QER090150). RNA was treated with DNaseI from the same
kit, reverse transcribed with AMV RT (Sigma 10109118001), and then cDNA were
quantified in multiplex TaqMan qPCR reactions using commercially available
probe sets (Thermo Fisher 4453320) and TaqMan FastAdvanced Master mix
(Thermo Fisher 4444556). Three to four technical qPCR replicates were used for
each biological replicate.
Flow cytometry for GATA1 protein levels. We devised a flow cytometry assay
wherein we co-culture cells expressing the sgRNA and mCherry from a lentivirus
with non-transduced cells and stain for GATA1 protein. Intracellular staining of
GATA1 protein levels was performed using a previously published method87.
Specifically, cells were fixed with Fix Buffer I (BD Biosciences) for 15 min at 37 °C.
Cells were washed with 10% FBS in PBS once and then permeabilized on ice for 30
min using Perm Buffer III (BD Biosciences). Cells were washed twice and then
stained with anti-GATA1 primary (1:1000, rabbit, Cell Signaling Technologies cat
no. 3535 S) for 1 h at 4 °C. After two more washes, cells were incubated with Goat
anti-rabbit antibody conjugated to Alexa Fluor 647 (1:1000, ThermoFisher cat no.
A-21244) for 1 h at 4 °C. After a final round of washing, flow cytometry was
performed using a FACScan flow cytometer (BD Biosciences). We analyzed the
data with CytoFlow by gating the cells on mCherry expression and then plot the
GATA1 protein level in mCherry + and non-transduced cells. This approach
controls for variability in staining efficiency as the two cell groups are mixed within
the same sample.
Western blot for GATA1 protein levels. Cells transduced with a lentiviral vector
containing an sgRNA and puromycin-T2A-mCherry were selected with puromycin
(1 μg/mL) until mCherry was >85%. 1 million cells were lysed in lysis buffer (1%
Triton X-100, 150 mM NaCl, 50 mM Tris pH 7.5, 1 mM EDTA, Protease inhibitor
cocktail). Protein amounts were quantified using the DC Protein Assay kit (Bio-
Rad). Equal amounts were loaded onto a gel and transferred to a nitrocellulose
membrane. Membrane was probed using GATA1 antibody (1:1000, rabbit, Cell
Signaling Technologies cat no. 3535 S) and GAPDH antibody (1:2000, mouse,
ThermoFisher cat no. AM4300) as primary antibodies. Donkey anti-rabbit IRDye
680 LT and goat anti-mouse IRDye 800CW (1:20,000 dilution, LI-COR Bios-
ciences, cat nos. 926–68023 and 926–32210, respectively) were used as secondary
antibodies. Blots were imaged on a LiCor Odyssey CLx. Uncropped images are
provided in the Source Data file.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The following datasets are accessible in the online GEO repository with accession
GSE131349: CRISPR-Cas9 screen data (tiling screens, dense-tiling screen, CTCF motif
screens), CTCF ChIP-seq, ATAC-seq, RNA-seq [GSE131349]. Source data for the figures
provided are available in the Source Data file. All other relevant data are available from
the authors upon reasonable request.
Code availability
Python scripts are available on GitHub for library design and guide scoring. (1) Library
design: extractGuidesFromGuideScan.py takes a list of regions and returns a desired
number of guides within each of those regions, filtering for either the number of off-
targets or the GuideScan specificity scores. (2) Screen analysis:
GuidesPerRegionFromWholeGenomeGuideScan.py takes a list of sgRNA sequences and
returns their GuideScan specificity scores (https://github.com/georgimarinov/
non_coding_CRISPR_screen_design). The underlying data, GuideScan scores for all
sgRNAs in the human hg38 genome and mouse mm10 genome, were downloaded from
the Guidescan webtool (www.guidescan.com), and are also provided to enable direct
batch processing.
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